Phosphorus

About:

Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.

Twitter/X: phosphorus

Top Investors: Gaingels, TQ Ventures, FirstMark, Vast Ventures, Wormhole Capital

Description:

Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine by making it cost-effective, accessible, and actionable for our patients. Phosphorus’s suite of clinical-grade genomics tests use next-generation sequencing (NGS) and are available to patients through healthcare providers, hospitals, and directly to consumers through its website. The Phosphorus laboratory is CLIA and CAP certified and licensed for testing in all 50 states.

Total Funding Amount:

$18M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)phosphorus.com

Founders:

Alexander Bisignano, Santiago Munne

Number of Employees:

11-50

Last Funding Date:

2023-01-01

IPO Status:

Private

Industries: